Bookbuilding IPO | ₹1,551 Cr | Listed at BSE, NSE | Fri, Aug 4, 2023 - Tue, Aug 8, 2023
| Category | QIB | NII | Retail | Employees | Total | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | Below ₹10L | Above ₹10L | Total NII | ||||
| Allocation (No. of shares) | 41,83,130 | 62,74,695 | 1,04,57,825 | 10,45,783 | 20,91,565 | 31,37,348 | 73,20,479 | 10,000 | 2,09,25,652 |
| Allotment price (Rs.) | 741 | 741 | 741 | 741 | 741 | 741 | 741 | 671 | 741 |
| No.of applications | 127 | 41 | 168 | 43,472 | 27,029 | 70,501 | 10,73,881 | 340 | 11,44,890 |
| No.of shares applied | 28,25,74,140 | 62,74,700 | 28,88,48,840 | 1,29,04,300 | 4,02,34,580 | 5,31,38,880 | 2,71,03,300 | 33,060 | 36,91,24,080 |
| Amount collected (Rs.cr.) | 20,938.74 | 464.96 | 21,403.70 | 956.21 | 2,981.38 | 3,937.59 | 2,008.35 | 2.22 | 27,350.86 |
| No.of times subscribed | 67.55 | 1.00 | 27.62 | 12.34 | 19.24 | 16.94 | 3.70 | 3.31 | 17.64 |
| No.of shares allotted | 41,83,130 | 62,74,695 | 1,04,57,825 | 10,45,783 | 20,91,565 | 31,37,348 | 73,20,479 | 10,000 | 2,09,25,652 |
| Amount (Rs.cr.) | 309.97 | 464.95 | 774.92 | 77.49 | 154.98 | 232.48 | 542.45 | 0.67 | 1,550.52 |
| No.of allottees | 127 | 41 | 168 | 3,734 | 7,469 | 11,203 | 3,66,023 | 208 | 3,77,602 |
Concord Biotech IPO is a public issue of 2.09 Cr equity shares. The issue offers 0.73 Cr shares to retail investors, 1.05 Cr shares to qualified institutional buyers, and 0.31 Cr shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| QIB | 1,04,57,825 | 774.92 | 49.98% |
| Anchor | 62,74,695 | 464.95 | 29.99% |
| QIB (Ex Anchor) | 41,83,130 | 309.97 | 19.99% |
| NII | 31,37,348 | 232.48 | 14.99% |
| bNII (> ₹10L) | 20,91,565 | 154.98 | 10.00% |
| sNII (< ₹10L) | 10,45,783 | 77.49 | 5.00% |
| Retail | 73,20,479 | 542.45 | 34.98% |
| Employee | 10,000 | 0.74 | 0.05% |
| Total | 2,09,25,652 | 1,550.59 | 100% |
A total of 62,74,695 shares at a price of Rs 741 per share will be allotted to the anchor investors.
| Anchor investors bid opening date | Aug 03, 2023 |
| Anchor investor price | ₹741.00 |
| Anchor investors as % of QIBs | 60.00% |
| No. of shares locked-in for 30 days | 31,37,348 |
| No. of shares locked-in for 90 days | 31,37,348 |
📑 Anchor Investor Allotment Letter
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Concord Biotech IPO is subscribed 24.87 times by Aug 08, 2023 19:02.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 67.67 |
| Non Institutional | 16.99 |
| Retail Individual | 3.78 |
| Employee Reservations | 24.48 |
| Total Subscription | 24.87 |
An investor can apply in Concord Biotech IPO online via bank (using ASBA) or the broker (using UPI). The Concord Biotech IPO shares are offered online only.
The Concord Biotech IPO is subscribed 24.87 times by Aug 08, 2023 19:02.
The Concord Biotech IPO allotment status is expected on or around Friday, August 11, 2023. Visit Concord Biotech IPO allotment status to check.
The Concord Biotech IPO listing date is August 18, 2023. The equity share of Concord Biotech IPO will list on BSE, NSE.
Visit Concord Biotech IPO subscription status page for real-time bidding information about Concord Biotech IPO.
| IPO opens On | Friday, August 4, 2023 |
| IPO Closes On | Tuesday, August 8, 2023 |
| Finalisation of Basis of Allotment | Friday, August 11, 2023 |
| Initiation of Refunds | Monday, August 14, 2023 |
| Credit of Shares to Demat Account | Thursday, August 17, 2023 |
| IPO Listing Date | Friday, August 18, 2023 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO Live News |
| IPO Allotment Status |
| IPO Basis of Allotment Document |
| IPO FAQs |
